HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PROF
Profound Medical Corp.
There isn't enough reported data to score PROF yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PROF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PROF's revenue is currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PROF PE Valuation
PROF has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PROF Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PROF's losses to shrink, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PROF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.93 | +$0.42 |
| Q2 2026 | -$0.98 | +$0.49 |
| Q1 2026 | -$1.24 | -$0.01 |
| Q4 2025 | -$1.41 | -$0.28 |
| Q3 2025 | -$1.35 | $0.00 |
| Q2 2025 | -$1.47 | -$0.24 |
| Q1 2025 | -$1.23 | +$0.07 |
| Q4 2024 | -$1.13 | +$0.23 |
PROF is still losing money, but less than at its worst: $0.93 per share over the past year, against $1.53 at its worst in early 2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over PROF on profitability, with a higher operating margin.
PROF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8M | +86% |
| Q2 2026 | $2.5M | +12% |
| Q1 2026 | $5.3M | +104% |
| Q4 2025 | $6M | +47% |
| Q3 2025 | $5.3M | +87% |
| Q2 2025 | $2.2M | -1% |
| Q1 2025 | $2.6M | +82% |
| Q4 2024 | $4.1M | +52% |
PROF's revenue has grown year over year for five quarters in a row: $10M last quarter, up 86% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -80% | +89 points |
| Q2 2026 | -446% | +179 points |
| Q1 2026 | -150% | +276 points |
| Q4 2025 | -123% | +77 points |
| Q3 2025 | -169% | +201 points |
| Q2 2025 | -624% | -273 points |
| Q1 2025 | -426% | +121 points |
| Q4 2024 | -200% | +2214 points |
PROF's operating margin was −80% last quarter, up 89 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
PROF has the stronger cash trend. Its trailing FCF is down 33% versus its history, compared with HIMS at down 84%.
PROF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5M | +$4.6M |
| Q2 2026 | -$11.3M | +$2.4M |
| Q1 2026 | -$8.6M | -$300K |
| Q3 2025 | -$9.6M | -$2.8M |
| Q2 2025 | -$13.7M | -$7.5M |
| Q1 2025 | -$8.3M | -$3.8M |
| Q4 2024 | -$5.6M | +$1.4M |
| Q3 2024 | -$6.8M | -$2.5M |
PROF has burned cash in almost every quarter: −$35M over the past year, against −$34M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PROF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PROF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +205K shares |
| 1 year | +21% | +6.5M shares |
| 3 years | +71% | +15.2M shares |
| 5 years | +79% | +16.1M shares |
| Available history | +826% | +32.6M shares |
PROF has 37M diluted shares, up 21% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PROF Net Leverage
PROF's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PROF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 57.1 | Neutral |
PROF's weekly RSI is 58 (neutral) and its Stochastic is 57 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PROF PE vs Healthcare Sector
PROF has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PROF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.41 | 16% above |
| 20 week MA | $6.65 | 12% above |
| 50 week MA | $6.77 | 9.9% above |
| 100 week MA | $6.31 | 18% above |
| 200 week MA | $7.97 | 6.6% below |
PROF has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
PROF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.7 | $21.0 | +97% |
| 2021 | $21.0 | $11.7 | -45% |
| 2022 | $11.7 | $10.2 | -13% |
| 2023 | $10.2 | $8.49 | -17% |
| 2024 | $8.49 | $7.15 | -16% |
| 2025 | $7.15 | $7.37 | +3.1% |
| 2026 YTD | $7.37 | $7.44 | +0.9% |
PROF has the edge over HIMS on returns for 2026, with the stronger performance.